Cargando…
Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases
BACKGROUND: To evaluate the recurrence patterns and survival outcomes of surgically treated relapsed ovarian clear cell carcinoma (OCCC) patients. METHODS: We performed a comprehensive retrospective analysis of all the patients who underwent secondary debulking from 2004/10 to 2019/04. RESULTS: In t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012237/ https://www.ncbi.nlm.nih.gov/pubmed/32104073 http://dx.doi.org/10.2147/CMAR.S242129 |
_version_ | 1783496202095951872 |
---|---|
author | Ye, Shuang Zhou, Shuling Chen, Wei Xiang, Libing Wu, Xiaohua Yang, Huijuan |
author_facet | Ye, Shuang Zhou, Shuling Chen, Wei Xiang, Libing Wu, Xiaohua Yang, Huijuan |
author_sort | Ye, Shuang |
collection | PubMed |
description | BACKGROUND: To evaluate the recurrence patterns and survival outcomes of surgically treated relapsed ovarian clear cell carcinoma (OCCC) patients. METHODS: We performed a comprehensive retrospective analysis of all the patients who underwent secondary debulking from 2004/10 to 2019/04. RESULTS: In total, 45 eligible patients were included. 75.6% of the patients had early-stage disease and platinum-sensitive recurrence accounted for 70.5%. The median progression-free survival after primary surgery (PFS 1) was 20 months (range, 2–137). Of all, 64.4% patients had solitary recurrence and 86.7% patients had no residual disease after secondary surgery. Regarding tumor distribution, the most common site was pelvis (47.5%), followed by lymph node metastases (18.0%) and abdominal wall lesions (8.2%). For the entire population, the median disease-free survival after recurrence (PFS 2) and post-relapse survival (PRS) was 15 months (range, 0–96), and 24 months (range, 3–159), respectively. Eight patients (17.8%) had a prolonged PFS2 more than 30 months. Patients with localized relapse had better survival including PFS 2 (P=0.023), PRS (P=0.004), and overall survival (OS) (P=0.029). Patients who achieved complete resection tended to have longer PFS 2 (P=0.017). After multivariate analysis, complete resection at recurrence remained as an independent positive predictor for PFS 2 (P=0.022). The median OS was 50 months and was significantly associated with platinum response (P=0.003) and number of relapsed lesions (P=0.002). CONCLUSION: A high rate of pelvic recurrence was noted in this population. Patients with focal recurrence had a favorable prognosis. Complete resection at secondary debulking proved to be an independent predictor for disease-free survival. |
format | Online Article Text |
id | pubmed-7012237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-70122372020-02-26 Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases Ye, Shuang Zhou, Shuling Chen, Wei Xiang, Libing Wu, Xiaohua Yang, Huijuan Cancer Manag Res Original Research BACKGROUND: To evaluate the recurrence patterns and survival outcomes of surgically treated relapsed ovarian clear cell carcinoma (OCCC) patients. METHODS: We performed a comprehensive retrospective analysis of all the patients who underwent secondary debulking from 2004/10 to 2019/04. RESULTS: In total, 45 eligible patients were included. 75.6% of the patients had early-stage disease and platinum-sensitive recurrence accounted for 70.5%. The median progression-free survival after primary surgery (PFS 1) was 20 months (range, 2–137). Of all, 64.4% patients had solitary recurrence and 86.7% patients had no residual disease after secondary surgery. Regarding tumor distribution, the most common site was pelvis (47.5%), followed by lymph node metastases (18.0%) and abdominal wall lesions (8.2%). For the entire population, the median disease-free survival after recurrence (PFS 2) and post-relapse survival (PRS) was 15 months (range, 0–96), and 24 months (range, 3–159), respectively. Eight patients (17.8%) had a prolonged PFS2 more than 30 months. Patients with localized relapse had better survival including PFS 2 (P=0.023), PRS (P=0.004), and overall survival (OS) (P=0.029). Patients who achieved complete resection tended to have longer PFS 2 (P=0.017). After multivariate analysis, complete resection at recurrence remained as an independent positive predictor for PFS 2 (P=0.022). The median OS was 50 months and was significantly associated with platinum response (P=0.003) and number of relapsed lesions (P=0.002). CONCLUSION: A high rate of pelvic recurrence was noted in this population. Patients with focal recurrence had a favorable prognosis. Complete resection at secondary debulking proved to be an independent predictor for disease-free survival. Dove 2020-02-07 /pmc/articles/PMC7012237/ /pubmed/32104073 http://dx.doi.org/10.2147/CMAR.S242129 Text en © 2020 Ye et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Ye, Shuang Zhou, Shuling Chen, Wei Xiang, Libing Wu, Xiaohua Yang, Huijuan Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases |
title | Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases |
title_full | Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases |
title_fullStr | Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases |
title_full_unstemmed | Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases |
title_short | Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases |
title_sort | recurrence patterns and survival outcomes in chinese patients with surgically treated recurrent ovarian clear cell carcinoma: a single institutional analysis of 45 cases |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012237/ https://www.ncbi.nlm.nih.gov/pubmed/32104073 http://dx.doi.org/10.2147/CMAR.S242129 |
work_keys_str_mv | AT yeshuang recurrencepatternsandsurvivaloutcomesinchinesepatientswithsurgicallytreatedrecurrentovarianclearcellcarcinomaasingleinstitutionalanalysisof45cases AT zhoushuling recurrencepatternsandsurvivaloutcomesinchinesepatientswithsurgicallytreatedrecurrentovarianclearcellcarcinomaasingleinstitutionalanalysisof45cases AT chenwei recurrencepatternsandsurvivaloutcomesinchinesepatientswithsurgicallytreatedrecurrentovarianclearcellcarcinomaasingleinstitutionalanalysisof45cases AT xianglibing recurrencepatternsandsurvivaloutcomesinchinesepatientswithsurgicallytreatedrecurrentovarianclearcellcarcinomaasingleinstitutionalanalysisof45cases AT wuxiaohua recurrencepatternsandsurvivaloutcomesinchinesepatientswithsurgicallytreatedrecurrentovarianclearcellcarcinomaasingleinstitutionalanalysisof45cases AT yanghuijuan recurrencepatternsandsurvivaloutcomesinchinesepatientswithsurgicallytreatedrecurrentovarianclearcellcarcinomaasingleinstitutionalanalysisof45cases |